| __timestamp | Taro Pharmaceutical Industries Ltd. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 580006000 | 1162636000 |
| Thursday, January 1, 2015 | 676585000 | 1396725000 |
| Friday, January 1, 2016 | 778966000 | 1526100000 |
| Sunday, January 1, 2017 | 671251000 | 1619600000 |
| Monday, January 1, 2018 | 463508000 | 1429100000 |
| Tuesday, January 1, 2019 | 445724000 | 1331200000 |
| Wednesday, January 1, 2020 | 399725000 | 1375200000 |
| Friday, January 1, 2021 | 296656000 | 1563000000 |
| Saturday, January 1, 2022 | 293122000 | 1789600000 |
| Sunday, January 1, 2023 | 268323000 | 2070000000 |
| Monday, January 1, 2024 | 304979000 |
Data in motion
In the competitive landscape of the pharmaceutical industry, United Therapeutics Corporation and Taro Pharmaceutical Industries Ltd. have showcased contrasting trajectories in their gross profit performance over the past decade. From 2014 to 2023, United Therapeutics consistently outperformed Taro, with its gross profit peaking at approximately 2.07 billion in 2023, marking a remarkable 78% increase from 2014. In contrast, Taro's gross profit saw a decline, dropping by over 50% from its 2016 peak to around 268 million in 2023. This divergence highlights United Therapeutics' robust growth strategy and market adaptability, while Taro faces challenges in maintaining its earlier momentum. The data for 2024 remains incomplete, leaving room for speculation on future trends. As these companies navigate the evolving pharmaceutical landscape, their financial performance offers valuable insights into their strategic directions and market positions.
Johnson & Johnson vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Sanofi and Taro Pharmaceutical Industries Ltd. Trends
Gross Profit Trends Compared: Zoetis Inc. vs United Therapeutics Corporation
Gross Profit Trends Compared: Regeneron Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
United Therapeutics Corporation and Incyte Corporation: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing United Therapeutics Corporation and Amneal Pharmaceuticals, Inc.
Gross Profit Trends Compared: United Therapeutics Corporation vs Arrowhead Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? United Therapeutics Corporation or Veracyte, Inc.
Gross Profit Trends Compared: United Therapeutics Corporation vs MiMedx Group, Inc.
Key Insights on Gross Profit: United Therapeutics Corporation vs BioCryst Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing Viatris Inc. and Taro Pharmaceutical Industries Ltd.
Pharming Group N.V. vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown